Dartmouth-Hitchcock Health just helped open two Phase III COVID-19–related therapeutic studies in six business days. The Gilead-sponsored studies, one of patients with moderate COVID-19 and the other with patients suffering more serious symptoms, are evaluating the safety and antiviral activity of Remdesivir (GS-5734™) against the condition.
The U.S. Food and Drug Administration (FDA) has issued a guidance authorizing the emergency use of ventilators, anesthesia gas machines modified for use as ventilators, and positive pressure breathing devices […]
From movie theaters to restaurants to shopping malls, coronavirus-inspired closures are already impacting the national economy in significantly negative ways. The same phenomenon appears to be damaging clinical trials, says […]
Lung cancer clinical trials supported by the pharmaceutical industry demonstrate no more bias than studies funded by other sources, according to a recent study published in the Journal of Thoracic Oncology, the official journal of the International Association for the Study of Lung Cancer.
The team at Greater Gift, an organization dedicated to honoring patient volunteers and research professionals who make clinical trials possible, is appealing to its clinical trial brethren to consider […]